Revenue
2022
2023
2024
2025
Apimeds Pharmaceuticals US, Inc. (APUS)
Price—Loading quote
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Research & development | $1.6M | $0 | $98,544 | $368,000 |
| Operating expenses | $11.9M | $1.3M | $747,436 | $639,529 |
| Operating income | −$11.9M | −$1.3M | −$747,436 | −$639,529 |
| EBITDA | −$11.9M | −$1.3M | −$739,625 | −$639,529 |
| Net income | −$6.0M | −$1.4M | −$777,694 | −$668,666 |
| Basic EPSper basic share | -$5.50 | -$1.80 | -$1.70 | -$0.58 |
| Diluted EPSper diluted share | -$5.50 | -$1.80 | -$1.70 | -$0.58 |
Owners
Reported shareholders
≈49.70%of listed shares
Emerson Erik C.750K shares · May 16, 2025
View holders
| Holder | % owned |
|---|---|
Inscobee Inc. | —2.1M shares |
Emerson Erik C. | ≈49.70%750K shares |
Koo Jakap | ≈42.67%643.89K shares |
Kim Christopher | ≈18.39%277.5K shares |
Hemenway Trust Co LLC | 18.16%274K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 4.22%63.65K shares |
GEODE CAPITAL MANAGEMENT, LLC | 2.33%35.11K shares |
VANGUARD FIDUCIARY TRUST CO | 1.59%24.04K shares |
JANE STREET GROUP, LLC | 1.06%15.99K shares |
UBS Group AG | 0.78%11.82K shares |
Tower Research Capital LLC (TRC) | 0.11%1.66K shares |
Percentages use 1.51M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Reported positions exceed 100% in total, so the circle shows the selected holder only.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 14, 2025Form 4 | Kim ChristopherChairman and CMO | BuyCommon Stock, par value $0.01 per share | 7.7K | $1.86 | $14.4K | 27.5K |
| May 13, 2025Form 4 | Kim ChristopherChairman and CMO | BuyCommon Stock, par value $0.01 per share | 19.8K | $1.82 | $36.0K | 19.8K |
| May 12, 2025Form 4 | Koo JakapDirector | BuyCommon Stock, par value $0.01 per share | 28.5K | $1.99 | $56.7K | 643.9K |
| May 12, 2025Form 4 | Inscobee Inc.TenPercentOwner | BuyCommon Stock, par value $0.01 per share | 500.0K | $4.00 | $2.00M | 1.98M |